WAM
ESPR

Wolverine Asset Management’s Esperion Therapeutics ESPR Stock Holding History

Wolverine Asset Management’s Portfolio ESPR Stock Details ESPR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-200
Closed -$196 – 1853
2023
Q3 		$196 Hold
200
– – ﹤0.01% 1802
2023
Q2 		$278 Hold
200
– – ﹤0.01% 1719
2023
Q1 		$318 Buy
+200
New +$1.03K ﹤0.01% 1785
2022
Q3 		– Sell
-27,800
Closed -$176K – 2416
2022
Q2 		$176K Sell
27,800
-4,300
-13% -$24.4K ﹤0.01% 1233
2022
Q1 		$148K Buy
32,100
+22,800
+245% +$97.8K ﹤0.01% 1224
2021
Q4 		$46K Buy
9,300
+7,000
+304% +$56K ﹤0.01% 1532
2021
Q3 		$27K Buy
2,300
+1,100
+92% +$16K ﹤0.01% 1563
2021
Q2 		$25K Hold
1,200
– – ﹤0.01% 1854
2021
Q1 		$33K Buy
+1,200
New +$35.4K ﹤0.01% 1704

Other funds holding ESPR

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $7.15B AUM 169.27% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return